GlassScriptPhysician profile
Chantal Hanjoul
NPI 1891017539
$494.40
in general payments reported to CMS, 2019-2025
5 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $95.76 · 2023: $62.42 · 2024: $17.60 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $221.54 | 2021-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $102.91 | 2021-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Organon LLC | $80.14 | 2021-2023 | Nexplanon |
| Pfizer INC. | $63.84 | 2021-2025 | |
| Sanofi Pasteur INC. | $25.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chantal Hanjoul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.